esketamine has been researched along with Borderline Personality Disorder in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kasper, S; Lanzenberger, R; Naderi-Heiden, A; Praschak-Rieder, N; Unterholzner, J; Vanicek, T | 1 |
| De Fazio, P; de Filippis, R | 1 |
2 other study(ies) available for esketamine and Borderline Personality Disorder
| Article | Year |
|---|---|
Intravenous esketamine leads to an increase in impulsive and suicidal behaviour in a patient with recurrent major depression and borderline personality disorder.
Topics: Antidepressive Agents; Borderline Personality Disorder; Depression; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Female; Humans; Impulsive Behavior; Ketamine; Suicidal Ideation | 2022 |
Esketamine nasal spray in severe bipolar depression with borderline personality disorder and history of multiple substance abuse: A case report.
Topics: Bipolar Disorder; Borderline Personality Disorder; Humans; Nasal Sprays; Substance-Related Disorders | 2023 |